Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Sep 2025 is 7.43% vs 0.20% in Sep 2024
Consolidate Net Profit
YoY Growth in quarter ended Sep 2025 is 80.00% vs -83.33% in Sep 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Sep 2025 is -80.13% vs 7.09% in Sep 2024
Interest
YoY Growth in quarter ended Sep 2025 is -26.09% vs 9.52% in Sep 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024
Compare Quarterly Results Of Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2025 is 6.23% vs -10.21% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 7.43% vs 0.20% in Sep 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is 106.77% vs -416.67% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 80.00% vs -83.33% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is -64.71% vs -53.55% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -80.13% vs 7.09% in Sep 2024
Quarterly - Interest
QoQ Growth in quarter ended Sep 2025 is -15.00% vs -20.00% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -26.09% vs 9.52% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024






